We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
Cap. Flow
-$2.77B
Cap. Flow %
-10.63%
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$366M
2
MSFT icon
Microsoft
MSFT
+$279M
3
AMZN icon
Amazon
AMZN
+$213M
4
TSLA icon
Tesla
TSLA
+$109M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Consumer Staples 11.79%
3 Consumer Discretionary 11.57%
4 Industrials 10.74%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMC icon
751
Commercial Metals
CMC
$7.63B
$900K ﹤0.01%
25,377
-863
-3% -$33.3K
LHCG
752
DELISTED
LHC Group LLC
LHCG
$898K ﹤0.01%
5,478
-88
-2% -$14.3K
FICO icon
753
Fair Isaac
FICO
$28.7B
$891K ﹤0.01%
2,163
-230
-10% -$104K
NTLA icon
754
Intellia Therapeutics
NTLA
$1.5B
$890K ﹤0.01%
15,916
+391
+3% +$24.3K
UNM icon
755
Unum
UNM
$13.8B
$889K ﹤0.01%
22,900
-2,391
-9% -$87.5K
OPCH icon
756
Option Care Health
OPCH
$3.4B
$885K ﹤0.01%
28,140
+4,382
+18% +$140K
GBT
757
DELISTED
Global Blood Therapeutics, Inc.
GBT
$872K ﹤0.01%
12,797
+728
+6% +$40.1K
SRC
758
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$869K ﹤0.01%
24,009
-571
-2% -$23.7K
SBRA icon
759
Sabra Healthcare REIT
SBRA
$5.64B
$867K ﹤0.01%
66,117
-2,093
-3% -$30.9K
QLYS icon
760
Qualys
QLYS
$4.84B
$866K ﹤0.01%
6,211
-75
-1% -$10.6K
ESNT icon
761
Essent Group
ESNT
$6.06B
$862K ﹤0.01%
24,735
-636
-3% -$25.5K
NWL icon
762
Newell Brands
NWL
$2.16B
$860K ﹤0.01%
61,843
+11,219
+22% +$209K
DINO icon
763
HF Sinclair
DINO
$15.9B
$858K ﹤0.01%
15,938
-853
-5% -$42.2K
PCTY icon
764
Paylocity
PCTY
$6.71B
$857K ﹤0.01%
3,551
-162
-4% -$37.2K
MUR icon
765
Murphy Oil
MUR
$5.58B
$853K ﹤0.01%
24,232
-352
-1% -$12.2K
CZR icon
766
Caesars Entertainment
CZR
$6.1B
$847K ﹤0.01%
26,291
-3,301
-11% -$144K
SAIA icon
767
Saia
SAIA
$11.3B
$845K ﹤0.01%
4,443
-72
-2% -$15.3K
ITCI
768
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$840K ﹤0.01%
18,025
+387
+2% +$20.2K
BPMC
769
DELISTED
Blueprint Medicines
BPMC
$828K ﹤0.01%
12,554
+224
+2% +$14.4K
COLD icon
770
Americold
COLD
$4.09B
$805K ﹤0.01%
32,709
-1,788
-5% -$54K
IBKR icon
771
Interactive Brokers
IBKR
$40.9B
$801K ﹤0.01%
50,120
+6,124
+14% +$94.3K
WYNN icon
772
Wynn Resorts
WYNN
$10.1B
$799K ﹤0.01%
12,696
-1,864
-13% -$116K
ONB icon
773
Old National Bancorp
ONB
$10.1B
$797K ﹤0.01%
48,342
-708
-1% -$11.8K
SEE
774
DELISTED
Sealed Air
SEE
$797K ﹤0.01%
17,894
-2,365
-12% -$130K
UHS icon
775
Universal Health Services
UHS
$9.43B
$786K ﹤0.01%
8,912
-1,280
-13% -$132K

Similar funds

ProShare Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.

  • ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
  • ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
  • ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
  • ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
  • ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
  • ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
  • ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.

Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.